Victoria Marks

Victoria Marks is a Postdoctoral Research Assistant in Neurotechnology at the University of Oxford's Institute of Biomedical Engineering. She holds a B.S. in Biomedical Engineering from the University of Miami (2017) and a Ph.D. in Biomedical Engineering and Physiology from the Mayo Clinic Graduate School of Biomedical Sciences (2023). Her research focuses on treating disorders of consciousness and improving chronic neuromodulation therapies, particularly in epilepsy and memory-related conditions.

Education:

• B.S., Biomedical Engineering, University of Miami, 2017
• Ph.D., Biomedical Engineering and Physiology, Mayo Clinic Graduate School of Biomedical Sciences, 2023

Research interests include neurotechnology, closed-loop systems, and the application of deep brain stimulation (DBS) to modulate memory, mood, and seizure activity. She has pioneered work on remote patient monitoring during the pandemic, integrating verbal memory tasks with DBS systems. Her postdoctoral work in the Denison Group (since 2023) advances adaptive neuromodulation strategies for neurological disorders.

Her publications span topics like DBS effects on verbal memory, seizure detection algorithms, and chronotherapy platforms. She has collaborated with Medtronic, Inc., developing stimulation artifact capture systems.

Advising and grants: As a postdoctoral researcher, she contributes to team-based projects but no formal advisees are listed. Her work aligns with grants focused on neurological engineering and clinical translation.

Labs/Teams: Active member of the Denison Group, specializing in neurotechnology and translational neuroscience.